Feraheme available for the treatment of iron deficiency anemia

Feraheme (ferumoxytol injection), an intravenous iron replacement therapy, has been made available by AMAG Pharmaceuticals for the treatment of iron deficiency anemia in adults with chronic kidney disease (CKD).

Feraheme is available in 17mL vials containing 510mg of ferumoxytol.

For more information call (877) 411-2510 or visit www.feraheme.com.